Dafo 10mg Tablets (14s)

Description

Dafo 10mg Tablets contain dapagliflozin, an oral medicine that lowers blood glucose by increasing urinary glucose excretion. It is used under medical supervision for type 2 diabetes and may also be prescribed for certain heart failure or chronic kidney disease indications.

• Manufacturer Name: Getz
• Drug Class: Sodium-glucose cotransporter-2 (SGLT2) inhibitor
• Dosage Form: Immediate-Release Tablet
• Storage: Store at room temperature, generally 20–25°C, in a dry place away from direct light and moisture. Keep out of reach of children and retain in the original packaging.
• Pack Size: Pack of 14 Tablets

Dafo 10mg Tablets (14s) Available Online in Pakistan

Dwatson offers Dafo 10mg Tablets (14s) at Rs. 210, with fast, discreet delivery across Pakistan.

Ingredients

• Dapagliflozin 10 mg

Benefits

• Helps improve blood glucose control in adults with type 2 diabetes mellitus alongside diet and exercise.
• May be prescribed to reduce the risk of hospitalization for heart failure in appropriate adults.
• May be prescribed to help reduce progression of chronic kidney disease in eligible patients.

Usage & Safety

For Adult

• Take once daily, with or without food, at approximately the same time each day.
• For type 2 diabetes, the usual starting dose is 5 mg once daily; the dose may be increased to 10 mg once daily when additional glycemic control is needed.
• For certain heart failure or chronic kidney disease indications, the usual dose is 10 mg once daily.
• Maintain adequate fluid intake unless a healthcare professional advises otherwise.
• Dosage should be individualized according to kidney function, treatment indication, tolerability, and other medicines being used.

For Children

• Safety and effectiveness for type 2 diabetes in children younger than 10 years have not been established.
• Use in children and adolescents for heart failure or chronic kidney disease should be directed by a specialist because safety and effectiveness are not established for all pediatric age groups.
• Do not use in children without specific medical supervision and age-appropriate prescribing.

Side Effects

• Common effects may include increased urination, thirst, genital fungal infections, urinary tract infections, dizziness, and dehydration.
• Low blood sugar is more likely when used with insulin or sulfonylureas.
• Serious effects requiring urgent medical attention include diabetic ketoacidosis, severe dehydration, fainting, serious urinary or genital infection, severe allergic reaction, and symptoms of kidney injury.
• Seek urgent care for nausea, vomiting, abdominal pain, unusual tiredness, difficulty breathing, confusion, or a sweet or metallic taste that may indicate ketoacidosis.

Contraindications

• Do not use in patients with a known serious hypersensitivity to dapagliflozin or any tablet ingredient.
• Not recommended for treatment of type 1 diabetes because of the risk of diabetic ketoacidosis.
• Use is generally avoided in patients on dialysis and requires careful assessment in severe kidney impairment.
• Use cautiously in patients with dehydration, low blood pressure, recurrent urinary or genital infections, or a history of diabetic ketoacidosis.
• Temporarily stop and seek medical advice during prolonged fasting, major surgery, severe illness, or significant fluid loss when advised by a healthcare professional.

Precautions & Warnings

• Insulin and sulfonylureas may increase the risk of hypoglycemia; dose adjustment may be required.
• Diuretics and other medicines that lower blood pressure may increase the risk of dehydration, low blood pressure, or dizziness.
• Medicines that affect kidney function or fluid balance require careful monitoring.
• Strong enzyme inducers such as rifampicin may reduce dapagliflozin exposure and effectiveness.
• Dapagliflozin may be taken with or without food; no specific food restriction is generally required, but excessive alcohol intake may increase dehydration or ketoacidosis risk.

Pregnancy

• Not recommended during pregnancy, particularly during the second and third trimesters, because fetal and neonatal kidney effects are a concern.
• Contact a healthcare professional promptly if pregnancy occurs while taking this medicine; an alternative glucose-lowering treatment may be needed.
• Breastfeeding is generally not recommended during treatment because potential effects on the infant kidney are uncertain.